Preliminary Human Radiation Dose Estimates of PET Renal Agents, Para-F-18-Fluorohippuric Acid and Ortho-I-124-Iodohippuric Acid from Rat Biodistribution Data

被引:2
作者
Cheki, Mohsen [1 ]
Papie, Maryam [2 ]
Mansi, Luigi [3 ]
Kitson, Sean [4 ]
Gali, Hariprasad [5 ]
机构
[1] Ahvaz Jundishapur Univ Med Sci, Fac Paramed, Dept Radiol Technol, Ahvaz, Iran
[2] Shiraz Univ, Dept Nucl Engn, Fac Mech Engn, Shiraz, Iran
[3] Univ Naples 2, Nucl Med, Naples, Italy
[4] Almac, Dept Biocatalysis & Isotope Chem, 20 Seagoe Ind Estate, Craigavon BT63 5QD, North Ireland
[5] Univ Oklahoma, Hlth Sci Ctr, Coll Pharm, Dept Pharmaceut Sci, Oklahoma City, OK 73190 USA
关键词
F-18-PFH; I-124-OIH; PET; para-F-18-fluorohippurate; ortho-I-124-iodohippurate; renal agent; tubular secretion; renography; dosimetry;
D O I
10.2174/1874471011666180212123534
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Para-F-18-fluorohippuric acid (F-18-PFH) and ortho-I-124-iodohippuric acid (I-124-OIH) were recently identified as potential radiotracers suitable for conducting renography using positron emission tomography (PET). The aim of this work was to estimate preliminary human-equivalent internal radiation dose of F-18-PFH and I-124-OIH using the biodistribution data reported in healthy rats. The results were compared with the absorbed dose data of technetium-99m-mercaptoacetyltriglycine (Tc-99m-MAG3) as documented in the International Commission on Radiological Protection (ICRP) publication 80. Methods: The medical internal radiation dose (MIRD) formula was applied to extrapolate data from rats to human and to project the absorbed radiation dose for various organs in humans. S factor was calculated by Monte-Carlo N-particle (MCNP) simulation. Results: Our dose prediction shows that an injection of F-18-PFH or I-124-OIH in humans would result in an estimated effective absorbed dose of 0.09 or 0.17 Sv/MBq respectively for whole body, which is about 135 or 73 times respectively lower than that obtained with an injection of Tc-99m-MAG3. All organs except kidneys would receive an estimated effective absorbed dose of <0.1 Sv/MBq for F-18-PFH or I-124-OIH. Kidneys would receive a dose of 0.83 or 0.77 Sv/MBq respectively for F-18-PFH or I-124-OIH. Conclusions: Our results indicate that F-18-PFH and I-124-OIH would deliver much safer levels and lower radiation doses to the patients compared to Tc-99m-MAG3 and warrants a clinical trial to estimate the radiation doses more accurately.
引用
收藏
页码:58 / 63
页数:6
相关论文
共 43 条
  • [1] [Anonymous], 1991, Ann ICRP, V21, P1
  • [2] [Anonymous], 1998, Ann ICRP, V28, P1
  • [3] [Anonymous], EV NUCL STRUCT DAT F
  • [4] Synthesis and In Vivo Evaluation of p-18F-Fluorohippurate as a New Radiopharmaceutical for Assessment of Renal Function by PET
    Awasthi, Vibhudutta
    Pathuri, Gopal
    Agashe, Hrushikesh B.
    Gali, Hariprasad
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (01) : 147 - 153
  • [5] Accurate dosimetry: an essential step towards good clinical practice in nuclear medicine
    Bacher, K
    Thierens, HM
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2005, 26 (07) : 581 - 586
  • [6] Bevelacqua J.J., 2005, RAD PROTECT MANAG, V22, P7
  • [7] A voxel-based mouse for internal dose calculations using Monte Carlo simulations (MCNP)
    Bitar, A.
    Lisbona, A.
    Thedrez, P.
    Maurel, C. Sai
    Le Forestier, D.
    Barbet, J.
    Bardies, M.
    [J]. PHYSICS IN MEDICINE AND BIOLOGY, 2007, 52 (04) : 1013 - 1025
  • [8] Cheki M, 2013, IRAN S MED J, V16, P296
  • [9] Cheki M, 2017, HELL J NUCL MED, V20, P241, DOI 10.1967/s002449910609
  • [10] Molecular Imaging of Urogenital Diseases
    Cho, Steve Y.
    Szabo, Zsolt
    [J]. SEMINARS IN NUCLEAR MEDICINE, 2014, 44 (02) : 93 - 109